Pulmonary Emphysema: all 64 studies
Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- Unilateral vs. Bilateral Lung Volume Reduction SurgeryRecruitingNCT07731958Not applicable
- Clinical Utility of LIBS Multi-Element Imaging and the IFF Algorithm in Chronic Lung DiseasesRecruitingNCT07597187
- A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)RecruitingNCT07555483Phase 3
- The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of EmphysemaRecruitingNCT06655428Not applicable
- Clinical-ultrasonographic Assessment of Pulmonary EmphysemaRecruitingNCT06533371Not applicable
- An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe EmphysemaRecruitingNCT06035120Not applicable
- Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin DeficiencyEnrolling by invitationNCT02796937Phase 3
- A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin DeficiencyCompletedNCT04722887Phase 1/2Results posted
- Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)CompletedNCT02719184Results posted
- Safety Study of Cell Therapy to Treat Chronic Obstructive Pulmonary DiseaseCompletedNCT01110252Not applicableResults posted
- Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease PatientsCompletedNCT00680056Phase 4Results posted
- The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) DeficiencyCompletedNCT00301366Phase 3Results posted
- Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient AdultsCompletedNCT00295061Phase 3Results posted
- Innovation in Pulmonary RehabilitationCompletedNCT00123422Not applicableResults posted
- Volumetric HRCT in Stable COPD Patients.CompletedNCT07809399
- Lung Diffusing Capacities Normality Thresholds in Pulmonary Fibrosis and EmphysemaCompletedNCT07091838
- Allogeneic MSC Treatment for Pulmonary EmphysemaStatus unknownNCT04918706Phase 2
- Video Assisted Thoracic Surgery (VATS) Fissure Completion Prior to Zephyr® Endobronchial Valve InsertionCompletedNCT04465461Not applicable
- Post-Market Clinical Evaluation of the Zephyr Valve 5.5-LP EBVCompletedNCT04161235
- Description of Bullous Emphysema Using Lung Ultrasound and Comparison to the Characteristics of PneumothoraxCompletedNCT04012359
- Clinical Study to Evaluate the Exercise Capacity in Patients With Severe Emphysema Treated With CoilsStatus unknownNCT02879331Not applicable
- Evaluation of Novel Lung Function Parameters in Patients With Chronic Obstructive Pulmonary Disease (COPD)Status unknownNCT02827721
- In Vivo Endomicroscopic Description of Pulmonary Microcirculation in Systemic Sclerosis and Emphysema PatientsTerminatedNCT02556697Not applicable
- A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the OL-BF-001 for Severe EmphysemaTerminatedNCT02470052Not applicable
- Diagnostic Value of Ultralow-dose Computed Tomography for the Detection of Pulmonary Nodules and Lung Parenchym Alterations Compared to Standard-dose CTStatus unknownNCT02468609Not applicable
- ICS/LABA Adherence and COPD ExacerbationCompletedNCT02446041
- Prevalence of Alpha-1 Antitrypsin Dysfunction in Pulmonary EmphysemaCompletedNCT02382367Not applicable
- Post-hospitalisation Nutritional Support and Gait Speed in COPDTerminatedNCT02261350Phase 3
- Low Cost Biological Lung Volume Reduction Therapy for Advanced EmphysemaCompletedNCT02107209Phase 2
- The Spiration Valve System for the Treatment of Severe EmphysemaCompletedNCT01989182Not applicable
- Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)CompletedNCT01983241Phase 3
- Safety Study of Bone-marrow Derived Mesenchymal Stromal Cells Associated With Endobronchial Valves in EmphysemaCompletedNCT01872624Not applicable
- The Effect and Mechanism of Bronchoscopic Lung Volume Reduction by Endobronchial Valve in Korean Emphysema PatientsCompletedNCT01869205Phase 3
- A Phase I Study of iPS Cell Generation From Patients With COPDCompletedNCT01860898Not applicable
- Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary EmphysemaWithdrawnNCT01849159Phase 1/2
- Evaluation of the Spiration® Valve System for Emphysema to Improve Lung FunctionCompletedNCT01812447Not applicable
- Long Term Follow up Investigation of Endobronchial Valves in EmphysemaTerminatedNCT01580215
- Collateral Ventilation Effects on Response to AeriSeal System Treatment in Upper Lobe Predominant EmphysemaTerminatedNCT01520740Phase 4
- Post Market Registry Study of the AeriSeal SystemTerminatedNCT01520064
- Is the Short Physical Performance Battery a Useful Outcome Measure in Chronic Obstructive Pulmonary DiseaseCompletedNCT01515709
- Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?CompletedNCT01507415
- eRT Remote Health MonitoringCompletedNCT01495780Not applicable
- AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral VentilationStatus unknownNCT01460108Phase 4
- Implantation of Endobronchial Valves Versus Intrabronchial Valves in Patients With Severe Heterogeneous EmphysemaCompletedNCT01457833Not applicable
- Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)TerminatedNCT01449292Phase 3
- ELVR in PH Patients With Severe EmphysemaCompletedNCT01393379
- A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced EmphysemaTerminatedNCT01320566Phase 2/3
- AeriSeal® System for Lung Volume Reduction in Patients With Advanced EmphysemaCompletedNCT01181466Phase 2/3
- AeriSeal System for Lung Volume ReductionCompletedNCT01051258Phase 1/2
- Unilateral Versus Bilateral Endoscopic Lung Volume Reduction A Comparative Case StudyStatus unknownNCT00995852Phase 2/3
- A Pilot Study to Evaluate the ROX Anastomotic Coupler System in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00992680Phase 2
- Diaphragmatic Mobility and Chronic Obstructive Pulmonary DiseaseCompletedNCT00870246
- Doxycycline and Airway Inflammation in Chronic Obstructive Pulmonary Disease (COPD)Status unknownNCT00857038Phase 4
- PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00683722Phase 2
- Randomized Comparison of Awake Nonresectional Versus Nonawake Resectional Lung Volume Reduction SurgeryCompletedNCT00566839Phase 2
- Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema StudyCompletedNCT00517998Phase 1
- US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema StudyCompletedNCT00515164Phase 2
- Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin DeficiencyCompletedNCT00460096Phase 2/3
- US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema StudyCompletedNCT00435253Phase 2
- US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema StudyCompletedNCT00347659Phase 1
- Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial FormulationTerminatedNCT00205920Phase 2
- Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial FormulationTerminatedNCT00205907Phase 1/2
- US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial FormulationCompletedNCT00085852Phase 1
- Yoga for Treating Shortness of Breath in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00051792Phase 1/2